The pathologic and clinical outcomes of risk-reducing salpingo-oophorectomy in asymptomatic carriers of homologous recombination repair gene mutation-Reference-Cited by-同舟云学术

The pathologic and clinical outcomes of risk-reducing salpingo-oophorectomy in asymptomatic carriers of homologous recombination repair gene mutation

Published:2025 Issue: Volume:36 Page:
ISSN:2005-0380
Container-title:Journal of Gynecologic Oncology
language:en
Short-container-title:J Gynecol Oncol

Author:

Lee Yeon Jee¹²^ORCID,Kim Ji Hyun¹^ORCID,Kim Youn Jee³^ORCID,Chang Yoon Jung⁴^ORCID,Kong Sun-Young⁵^ORCID,Yoo Chong Woo⁶^ORCID,Lee Dong Ock¹^ORCID,Seo Sang-Soo¹^ORCID,Kang Sokbom¹^ORCID,Park Sang-Yoon¹^ORCID,Lim Myong Cheol¹⁷⁸^ORCID

Affiliation:

1. Center for Gynecologic Cancer, Hospital, National Cancer Center, Goyang, Korea.

2. Department of Obstetrics and Gynecology, Myongji Hospital, Goyang, Korea.

3. Department of Obstetrics and Gynecology, Seoul National University College of Medicine, Seoul, Korea.

4. Department of Family Medicine, Research Institute and Hospital, National Cancer Center, Goyang, Korea.

5. Department of Laboratory Medicine and Genetic Counseling Clinic, Hospital, National Cancer Center, Goyang, Korea.

6. Center for Gynecologic Cancer and Department of Pathology, Research Institute and Hospital, National Cancer Center, Goyang, Korea.

7. Rare and Pediatric Cancer Branch and Immuno-Oncology Branch, Division of Rare and Refractory Cancer, Research Institute and Center for Clinical Trial, Hospital, National Cancer Center, Goyang, Korea.

8. Department of Cancer Control and Policy, Graduate School of Cancer Science and Policy, National Cancer Center, Goyang, Korea.

Publisher

XMLink

Link

https://ejgo.org/pdf/10.3802/jgo.2025.36.e15

Reference28 articles.

1. Risk-Reducing Salpingo-oophorectomy in Women with aBRCA1orBRCA2Mutation

2. Association of Risk-Reducing Surgery in BRCA1 or BRCA2 Mutation Carriers With Cancer Risk and Mortality

3. Time to stop ovarian cancer screening in BRCA1/2 mutation carriers?

4. Genetic/Familial High-Risk Assessment: Breast, Ovarian, and Pancreatic, Version 2.2021, NCCN Clinical Practice Guidelines in Oncology

5. Mortality after bilateral salpingo-oophorectomy in BRCA1 and BRCA2 mutation carriers: a prospective cohort study